Zubizarreta, P A <br/><br/>
Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.  [electronic resource] 

 -  Pediatric hematology and oncology  Mar 2000 
 - 155-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0888-0018 
<br/><br/><label>Standard No.: </label>10.1080/088800100276514  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Child, Preschool<br/>Cytogenetics<br/>Dexamethasone--therapeutic use<br/>Disease-Free Survival<br/>Disseminated Intravascular Coagulation--chemically induced<br/>Drug Administration Schedule<br/>Female<br/>Fibrin Fibrinogen Degradation Products--metabolism<br/>Fibrinogen--metabolism<br/>Hemorrhage--drug therapy<br/>Hemorrhagic Disorders--prevention & control<br/>Humans<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Male<br/>Platelet Count<br/>Retrospective Studies<br/>Risk Factors<br/>Survival<br/>Time Factors<br/>Tretinoin--administration & dosage